Medicool Technologies

ROCHESTER, MN · Founded 2020 · Medtech · Private

Implantable device that achieves painless termination of atrial fibrillation through non-destructive temporary cardiac tissue conduction delay

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
ROCHESTER, MN
Founded
2020
Latest Form D
$675K, Nov 2020
Total capital
$1.6M
Federal grants
$896K
2 awards · 2016–2018
Rank in peer group#20 of 445
Private capital raised
$675K
1 Form D · last Nov 2020
72 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
8 pending · first 2022
Rank in peer group#88 of 445

Capital timeline

20162017201820192020FEDERAL ↑EQUITY ↓Cumulative $1.6M$225K$671K1st Form D$675K
20162017201820192020FEDERAL ↑EQUITY ↓Cumulative $1.6M$225K$671K1st Form D$675K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$675K
  • Federal grantNSF · Phase II · SBIR Phase II: Novel Defibrillator$671K
  • Federal grantNSF · Phase I · SBIR Phase I: Novel Defibrillator$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

47months

from Medicool Technologies’s first federal award to its first private round.

First federal award · Dec 2016
NSF · $225K
First Form D · Nov 2020
$675K · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#20 · top 4%
  • Granted patents#88 · top 20%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Allan WitzExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeff RynbrandtExecutive Officer, DirectorNamed in SEC Form D filings
  • Paul FriedmanExecutive Officer, DirectorNamed in SEC Form D filings
  • Paul WilliamsDirectorNamed in SEC Form D filings
  • Rich SandersDirectorNamed in SEC Form D filings
  • Sam AsirvathamExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 10
  • GrantedImplantable Medical Devices And Methods Of UseUSPTOUS 12,636,490
  • PendingMedical Device Systems For Thermal TherapyUSPTOApplication 19085807
  • PendingImplantable Medical Devices And Methods Of UseUSPTOApplication 18797066
Show all 10 patent records
  • Implantable Medical Devices And Methods Of UseMay 26, 2026 · US 12,636,490Granted
  • Medical Device Systems For Thermal TherapyNov 20, 2025 · Application 19085807Pending
  • Implantable Medical Devices And Methods Of UseFeb 13, 2025 · Application 18797066Pending
  • Medical Device Systems For Thermal TherapySep 21, 2023 · Application 18118490Pending
  • Implantable Thermal Therapy DevicesMay 17, 2022 · US 11,331,215Granted
  • Implantable Medical Devices And Methods Of UseApplication 63187994Pending
  • Implantable Thermal Therapy DevicesApplication PCTUS2018038266Pending
  • Medical Device Systems For Thermal TherapyApplication 63320862Pending
  • Implantable Medical Devices And Methods Of UseApplication 63531143Pending
  • Medical Device Systems For Thermal TherapyApplication 63647956Pending
  • Medicool Technologies Inc.Shares a founder: Arjun Sharma
  • AMPHIX BIO, INC.Similar federal contract value in Medtech · null in contracts
  • I-FUNCTION, INC.Similar federal contract value in Medtech · null in contracts
  • Ion Dx, Inc.Similar federal contract value in Medtech · null in contracts
  • CORINNOVA INCSimilar federal contract value in Medtech · null in contracts
  • ONEBREATH, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .